from granny storm crows list 2012
CANNABIS AND DIABETES
Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes (abst - 2004)
http://abstracts.iov...ourcetype=HWCIT
The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
(abst – 2004)
http://www.ncbi.nlm....pubmed/15519750
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (full - 2005)
http://www.ncbi.nlm....?tool=pmcentrez
Activation of the Peripheral Endocannabinoid System in Human Obesity
(full - 2005)
http://www.ncbi.nlm....?tool=pmcentrez
Gpr40 Gene Expression in Human Pancreas and Insulinoma. (abst – 2005)
http://medical-journ...-and-insulinoma
The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse. (abst – 2005)
http://medical-journ...stasis-in-mouse
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes (full - 2006)
http://www.ncbi.nlm....72/?tool=pubmed
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia (full - 2006)
http://jcem.endojour...3eee8eb61349982
Weight Control in Individuals With Diabetes (full - 2006)
http://care.diabetes...ourcetype=HWCIT
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. (abst – 2006)
http://www.ncbi.nlm....pubmed/17011761
Expression of the Gene for a Membrane-bound Fatty Acid Receptor in the Pancreas and Islet Cell Tumours in Humans: Evidence for Gpr40 Expression in
Pancreatic Beta Cells and Implications for Insulin Secretion. (abst – 2006)
http://medical-journ...sulin-secretion
The Cannabinergic System as a Target for Anti-inflammatory Therapies
(abst - 2006)
http://www.ingentaco...000013/art00008
Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says
(news - 2006)
http://www.norml.org...m?Group_ID=6909
Marijuana Compound May Help Stop Diabetic Retinopathy (news - 2006)
http://www.scienceda...60227184647.htm
Cannabidiol, a marijuana compound, may help stop diabetic retinopathy (news – 2006)
http://www.xagena.it...58dd0b6f17.html
Marijuana Compound Offers Hope In Diabetic Retinopathy Prevention (news – 2006)
http://www.bio-medic...vention-8121-1/
Cannabidiol reduces the development of diabetes in an animal study (news - 2006)
http://www.cannabis-...el.php?id=219#3
Getting Eye On Cannabinoids (news - 2006)
http://www.thehempir...on_cannabinoids
Marijuana compound could prevent eye damage in diabetics (news - 2006)
http://www.thehempir...ge_in_diabetics
Cannabidiol arrests onset of autoimmune diabetes in NOD mice (full - 2007)
http://safeaccess.ca...acology2007.pdf
263
Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy
(full - 2007)
http://jpet.aspetjou...ourcetype=HWCIT
Cannabidiol attenuates high-induced endothelial cell inflammatory response and barrier disruption (full - 2007)
http://www.pubmedcen...&tool=pmcentrez
US Patent Application 20070099987 - Treating or preventing diabetes with cannabidiol
(full – 2007)
http://www.patentsto...7/fulltext.html
Role of cannabinoid CB2 receptors in glucose homeostasis in rats (abst – 2007)
http://www.sciencedi...01429990700249X
The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells (abst - 2007)
http://lib.bioinfo.pl/pmid:17604177
Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model (abst - 2007)
http://marijuana.res...ive/4/4/736.htm
Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full - 2008)
http://www.ncbi.nlm....?tool=pmcentrez
The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids (full – 2008)
http://diabetes.diab...9e-4650931c5e25
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full - 2008)
http://www.ncbi.nlm....?tool=pmcentrez
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full - 2008)
http://www.nature.co...by2007106a.html
Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. (full - 2008)
http://www.ncbi.nlm....95/?tool=pubmed
Endocannabinoids and the Control of Energy Homeostasis (full – 2008)
http://www.jbc.org/c...96-7fd75bb49403
Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full – 2008)
http://www.iovs.org/...49/12/5526.full
Presence of functional cannabinoid receptors in human endocrine pancreas. (abst – 2008)
http://www.ncbi.nlm....pubmed/18092149
264
Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. (full - 2009)
http://www.ncbi.nlm....20/?tool=pubmed
Cannabinoids as novel anti-inflammatory drugs. (full - 2009)
http://www.ncbi.nlm....14/?tool=pubmed
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full - 2009)
http://www.ncbi.nlm....60/?tool=pubmed
The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant (full - 2009)
http://www.ncbi.nlm....?tool=pmcentrez
Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes (abst - 2009)
http://www.unboundme..._L1_adipocytes_
Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. (abst – 2009)
http://www.ncbi.nlm....pubmed/19131941
Beneficial effects of a Cannabis sativa extract on diabetes induced neuropathy and oxidative stress. (abst - 2009)
http://www.unboundme...idative_stress_
Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug (news – 2009)
http://www.thefreeli......-a0202701009
Expression and function of cannabinoid receptors in mouse islets. ( full – 2010)
http://www.landesbio...LiISLETS2-5.pdf
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full - 2010)
http://www.ncbi.nlm....?tool=pmcentrez
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full - 2010)
http://www.ncbi.nlm....48/?tool=pubmed
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy (full – 2010)
http://diabetes.diab...cc-4aec5dfac384
265
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full – 2010)
http://content.karge...name=320527.pdf
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients (full - 2010)
http://www.lipidworl.../content/9/1/43
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.
(full – 2010)
http://diabetes.diab...826.long#sec-25
Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes. (full - 2010)
http://www.ncbi.nlm....07/?tool=pubmed
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
(full - 2010)
http://www.natap.org...s/marijuana.pdf
Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes? (full – 2010)
http://www.jci.org/a...ew/44099?search[abstract_text]=&search[article_text]=cannabinoid&
search[authors_text]=&search[fpage]=&search[title_text]=&search[volume]=
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst – 2010)
http://www.ncbi.nlm....pubmed/20937249
AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst – 2010)
http://www.ncbi.nlm....pubmed/20816753
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. (abst – 2010)
http://www.springerl...37q1lh40l15161/
GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst – 2010)
http://www.ncbi.nlm....pubmed/21094910
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.
(abst – 2010)
http://www.unboundme...i_inflammation_
Pot Compound Mitigates Diabetic Cardiomyopathy (news - 2010)
http://www.norml.org...m?Group_ID=8424
266
Cannabinoids inhibit and may prevent neuropathic pain in diabetes. (news - 2010)
http://medigardens.b...it-and-may.html
Lab Notes: Pot Has Benefits for Diabetic Hearts (news - 2010)
http://www.medpageto.../LabNotes/23853
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full– 2011)
http://www.ncbi.nlm....75/?tool=pubmed
Role for cannabinoid receptors in human proximal tubular hypertrophy. (full– 2011)
http://content.karge...0323997&typ=pdf
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. (abst – 2011)
http://www.unboundme...cardiomyopathy_
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis (abst – 2011)
http://diabetes.diab...4/1055.abstract
Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells (abst – 2011)
http://diabetes.diab...cc-4aec5dfac384
Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. (abst – 2011)
http://www.ncbi.nlm....pubmed/21340622
Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. (abst – 2011)
http://www.unboundme..._of_Langerhans_
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.
(abst – 2011)
http://www.ncbi.nlm....pubmed/21885477
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy. (abst – 2011)
http://www.ncbi.nlm....pubmed/21810593
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes. (abst – 2011)
http://www.unboundme...us_on_Diabetes_
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. (abst – 2011)
http://www.ncbi.nlm....pubmed/21238581
267
Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression. (abst – 2011)
http://www.unboundme...nos_expression_
GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (abst – 2011)
http://endo.endojour...b3-fea533824b24
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation (abst - 2011)
http://abstracts.iov...ourcetype=HWCIT
The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (abst – 2011)
http://www.ncbi.nlm....pubmed/22029844
The Endocannabinoid System: Plant-Derived Cannabinoids in Diabetes and Diabetic Complications. (abst – 2011)
http://www.ncbi.nlm....pubmed/22155112
Takeda moves potential first-in-class diabetes drug into phase III (news – 2011)
http://www.inpharm.c...k-875-phase-iii
This post has been edited by twigs: 21 March 2012 - 08:40 PM